Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study: M.A. Mittleman, M. Maclure, M.A. Lewis, G.C. Hall, N. Moore, F. Giuliano, H. Porst, H. Hedelin, A. Martin-Morales, R.E. Sobel, R. Reynolds, and D.B. Glasser.
Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonMAUSA.
Murray A
MA
Mittleman
McGill UniversityMontrealQuebecCanada.
Serge
S
Carrier
Cooper Medical School of Rowan UniversityCamdenNJUSA.
Allen D
AD
Seftel
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D013450:Sulfones / Q000009:adverse effects*
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones